Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$833
|
$784B |
13.5x |
31.3x |
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$191
|
$491B |
5.3x |
14.4x |
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$230
|
$471B |
7.9x |
17.4x |
Roche
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Imaging & Diagnostics
|
CHF 292
|
$315B |
4.1x |
10.3x |
AstraZeneca
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£128
|
$289B |
5.0x |
14.4x |
Novartis
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 105
|
$278B |
5.0x |
12.3x |
Novo Nordisk
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 377
|
$272B |
5.7x |
11.7x |
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$86
|
$242B |
3.7x |
8.3x |
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$290
|
$204B |
5.8x |
11.2x |
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$117
|
$165B |
5.7x |
11.1x |
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$44
|
$127B |
2.7x |
8.0x |
Sanofi
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
€83
|
$125B |
2.4x |
8.1x |
GSK
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
£16
|
$105B |
2.5x |
7.4x |
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$408
|
$99.7B |
8.5x |
22.5x |
CSL
|
Australia |
Biopharmaceuticals,
Vaccines & Immunotherapies
|
AUD 209
|
$75.9B |
4.8x |
14.2x |
Chugai Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 7479
|
$73.7B |
9.2x |
18.2x |
Takeda Pharmaceuticals
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4222
|
$70.3B |
2.4x |
8.9x |
Bayer
|
Germany |
Biopharmaceuticals,
Agriculture,
Drug Development & Therapeutics,
Health & Beauty
|
€28
|
$69.5B |
1.3x |
6.3x |
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$141
|
$67.9B |
7.2x |
16.4x |
Merck KGaA
|
Germany |
Biopharmaceuticals,
Drug Development & Therapeutics,
Advanced Materials
|
€116
|
$67.4B |
2.8x |
9.7x |
Jiangsu Hengrui Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 69
|
$58.7B |
12.9x |
43.7x |
Jiangsu Hengrui Pharma
|
Hong Kong |
Biopharmaceuticals
|
HKD 75
|
$58.7B |
12.9x |
43.9x |
Lonza Group
|
Switzerland |
Contract Research & Manufacturing,
Biopharmaceuticals
|
CHF 527
|
$50.5B |
5.5x |
18.8x |
Daiichi Sankyo
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4064
|
$46.7B |
3.6x |
16.9x |
Sun Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1671
|
$42.4B |
6.9x |
24.2x |
Teva Pharmaceuticals
|
Israel |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ILS 66
|
$38.7B |
2.2x |
7.7x |
Sandoz
|
Switzerland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CHF 49
|
$30.6B |
2.7x |
13.1x |
Celltrion
|
South Korea |
Biopharmaceuticals
|
KRW 173600
|
$28.6B |
10.0x |
29.2x |
Otsuka Holdings
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
JPY 8107
|
$26.5B |
1.7x |
7.2x |
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$147
|
$25.3B |
2.6x |
7.8x |
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$25.3B |
1.8x |
6.0x |
Hansoh Pharma
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 36
|
$23.9B |
12.1x |
32.5x |
Astellas Pharma
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1621
|
$23.1B |
1.8x |
8.7x |
Bausch Health
|
Canada |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Health & Beauty
|
CAD 9
|
$22.3B |
2.2x |
6.5x |
Royalty Pharma
|
United States of America |
Biopharmaceuticals
|
$36
|
$22.1B |
7.6x |
8.0x |
Sichuan Biokin
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 359
|
$20.8B |
50.7x |
314.7x |
Innovent Biologics
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 94
|
$19.8B |
12.1x |
132.0x |
Grifols
|
Spain |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€10
|
$17.7B |
2.1x |
8.4x |
Alteogen
|
South Korea |
Biopharmaceuticals
|
KRW 461000
|
$17.0B |
106.1x |
179.8x |
Sino Biopharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 8
|
$16.8B |
3.7x |
14.2x |
Genmab
|
Denmark |
Drug Development & Therapeutics,
Biopharmaceuticals
|
DKK 2044
|
$16.7B |
4.7x |
12.5x |
Akeso
|
Hong Kong |
Drug Development & Therapeutics,
Biopharmaceuticals
|
HKD 128
|
$14.8B |
33.6x |
-2951.3x |
Recordati
|
Italy |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€51
|
$14.6B |
4.9x |
13.1x |
Kelun-Biotech
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 489
|
$14.0B |
51.6x |
-331.6x |
Torrent Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 3533
|
$13.7B |
9.9x |
30.3x |
Fosun Pharma
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
CNY 28
|
$13.5B |
2.3x |
13.4x |
Cipla
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1562
|
$13.0B |
4.1x |
16.3x |
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$137
|
$13.0B |
4.8x |
20.9x |
CSPC Pharma Group
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 10
|
$12.7B |
3.1x |
11.6x |
Yunnan Baiyao Group
|
China |
Biopharmaceuticals,
Health & Beauty
|
CNY 57
|
$12.4B |
2.1x |
14.9x |
Mankind Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
INR 2459
|
$12.1B |
7.9x |
31.3x |
Sobi
|
Sweden |
Biopharmaceuticals,
Drug Development & Therapeutics
|
SEK 300
|
$12.1B |
4.2x |
11.3x |
Financiere de Tubize
|
Belgium |
Biopharmaceuticals
|
€234
|
$12.0B |
N/A |
N/A |
CR Pharmaceutical
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics,
Pharmacies
|
HKD 5
|
$11.8B |
0.3x |
5.3x |
Dr. Reddy's Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1265
|
$11.6B |
3.1x |
12.1x |
Orion
|
Finland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€69
|
$11.4B |
5.4x |
14.6x |
Wuxi XDC
|
Hong Kong |
Contract Research & Manufacturing,
Biopharmaceuticals
|
HKD 72
|
$10.8B |
13.9x |
44.4x |
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$10.8B |
1.7x |
5.5x |
Zhejiang NHU
|
China |
Biopharmaceuticals,
Nutraceuticals & Cosmeceuticals
|
CNY 25
|
$10.7B |
3.3x |
8.1x |
Zydus Lifesciences
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 993
|
$10.7B |
3.9x |
13.8x |
Ipsen
|
France |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€117
|
$10.5B |
2.5x |
6.9x |
Lupin
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1960
|
$10.3B |
3.8x |
15.7x |
Shionogi
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices
|
JPY 2484
|
$10.3B |
3.3x |
8.4x |
Huadong Medicine
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 41
|
$9.8B |
1.6x |
12.5x |
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$64
|
$8.5B |
6.7x |
10.3x |
Lundbeck
|
Denmark |
Biopharmaceuticals,
Drug Development & Therapeutics
|
DKK 44
|
$8.4B |
N/A |
N/A |
Eisai Co.
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 4611
|
$8.2B |
1.6x |
12.6x |
3SBio
|
Hong Kong |
Biopharmaceuticals
|
HKD 28
|
$7.9B |
3.5x |
6.0x |
Aurobindo Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1130
|
$7.4B |
2.0x |
9.8x |
RemeGen
|
Hong Kong |
Biopharmaceuticals
|
HKD 98
|
$7.3B |
19.8x |
-269.3x |
Imeik Technology Development
|
China |
Biopharmaceuticals
|
CNY 180
|
$7.2B |
18.1x |
25.4x |
Changchun High-Tech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 136
|
$7.2B |
3.8x |
14.7x |
Abivax
|
France |
Drug Development & Therapeutics,
Biopharmaceuticals
|
€79
|
$7.1B |
762.8x |
-35.3x |
Alkem Laboratories
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Nutraceuticals & Cosmeceuticals
|
INR 5455
|
$7.1B |
4.6x |
23.2x |
Abbott India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Medical Devices,
Nutraceuticals & Cosmeceuticals
|
INR 30176
|
$6.9B |
9.1x |
33.9x |
Biocon
|
India |
Biopharmaceuticals,
Contract Research & Manufacturing
|
INR 353
|
$6.8B |
3.7x |
17.7x |
Hebei Changshan
|
China |
Biopharmaceuticals
|
CNY 50
|
$6.7B |
N/A |
N/A |
Hikma Pharmaceuticals
|
United Kingdom of Great Britain and Northern Ireland |
Biopharmaceuticals,
Drug Development & Therapeutics
|
£18
|
$6.7B |
2.0x |
7.7x |
Kyowa Kirin
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 2319
|
$6.4B |
2.0x |
8.9x |
Shanghai RAAS
|
China |
Biopharmaceuticals
|
CNY 7
|
$6.4B |
5.6x |
18.9x |
Yuhan
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics
|
KRW 120478
|
$6.3B |
4.1x |
53.8x |
China Resources Sanjiu
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 29
|
$6.3B |
1.5x |
7.9x |
Glenmark Pharma
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics
|
INR 1939
|
$6.2B |
3.9x |
20.5x |
Krka
|
Slovenia |
Biopharmaceuticals,
Drug Development & Therapeutics
|
€196
|
$6.1B |
2.6x |
7.9x |
Gan and Lee
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 74
|
$5.9B |
10.4x |
32.5x |
PharmaEssentia
|
Taiwan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
TWD 536
|
$5.8B |
12.6x |
40.3x |
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$10
|
$5.6B |
1.9x |
8.5x |
Ono Pharmaceutical
|
Japan |
Biopharmaceuticals,
Drug Development & Therapeutics
|
JPY 1805
|
$5.5B |
1.7x |
7.5x |
Henlius Biotech
|
Hong Kong |
Biopharmaceuticals
|
HKD 72
|
$5.4B |
6.4x |
29.2x |
Gedeon Richter
|
Hungary |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HUF 10600
|
$5.4B |
2.0x |
5.2x |
Shanghai Junshi
|
Hong Kong |
Biopharmaceuticals,
Drug Development & Therapeutics
|
HKD 40
|
$5.2B |
15.5x |
-58.4x |
Dottikon ES Holding
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 310
|
$5.2B |
N/A |
N/A |
Bachem
|
Switzerland |
Chemicals,
Biopharmaceuticals
|
CHF 56
|
$5.1B |
6.2x |
21.7x |
Beijing Tiantan
|
China |
Biopharmaceuticals
|
CNY 19
|
$5.1B |
5.5x |
14.2x |
Metsera
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$53
|
$5.0B |
N/A |
N/A |
GSK India
|
India |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies,
Health & Beauty
|
INR 2764
|
$5.0B |
11.3x |
35.8x |
Peptron
|
South Korea |
Biopharmaceuticals,
Drug Development & Therapeutics,
Drug Delivery Systems
|
KRW 294500
|
$4.7B |
N/A |
N/A |
Amoytop Biotech
|
China |
Biopharmaceuticals,
Drug Development & Therapeutics
|
CNY 82
|
$4.6B |
9.2x |
30.8x |
Aspen Pharmacare
|
South Africa |
Biopharmaceuticals,
Drug Development & Therapeutics
|
ZAR 99
|
$4.3B |
1.7x |
9.6x |